Norwegian Spontaneous Coronary Artery Dissection Study
The Norwegian Spontaneous Coronary Artery Dissection Study (NOR-SCAD) is a national, multicenter prospective observational study conducted at major hospitals in Norway. The study investigates risk factors and complications of spontaneous coronary artery dissection (SCAD). Patients aged 18 years or older who are hospita
| Condition(s) | SCAD, Myocardial Infarction (MI), Women |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | The Norwegian Spontaneous Coronary Artery Dissection Study (NOR-SCAD) is a national, multicenter prospective observational study conducted at major hospitals in Norway. The study investigates risk factors and complications of spontaneous coronary artery dissection (SCAD). Patients aged 18 years or older who are hospitalized with SCAD are recruited during the index hospitalization. Each participant will be followed for 52 weeks with scheduled visits at 8 and 12 weeks and a final phone call at 52 weeks. Evaluations include coronary CT angiography (CTA), cardiac assessments, genetic analyses, blood sampling, structured questionnaires, and a cardiopulmonary exercise test (CPET). |
| Who can participate | Inclusion Criteria: * Spontaneous coronary artery dissection Exclusion Criteria: * Severe kidney failure * Severe allergic reaction to contrast |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Oslo University Hospital |
| Locations | Bergen, Norway; Oslo, Norway; Oslo, Norway |
| Start date | 2025-04-01 |
| NCT ID | NCT07317323 |
| Official listing | https://clinicaltrials.gov/study/NCT07317323 |